| CHAPTER
FIVE Annex 5 |
|
(Choice of drugs should be based on antibiotic sensitivity studies in
a specific area) |
Treat
For
|
Drugs
-- Depending on Sensitivity Studies
|
Adult
Dose (for uncomplicated or early infections)
|
|
Gonorrhoea |
Ciprofloxacin
(1) |
500
mg -single dose -oral |
|
Spectinomycin |
2
g -single dose -IM |
|
|
Cefixime |
400
mg -single dose -oral |
|
|
Ceftriaxone |
250
mg -single dose -IM |
|
|
Kanamycin |
2
g -single dose -IM |
|
|
Sulfamethoxazole/
Trimethoprim |
400mg/
80mg -10 tabs once daily for 3 days |
|
|
Chlamydia |
Doxycycline
(1) |
100
mg -twice daily for 7 days -oral |
|
Tetracycline
(1) |
500
mg -four times a day for 7 days -oral |
|
|
Erythromycin |
500
mg -four times a day for 7 days -oral |
|
|
Sulfafurazole |
500
mg -four times a say for 10 days -oral |
|
|
Syphilis |
Benzathine
penicillin G |
2.4
MUs -single dose -IM |
|
Procaine
penicillin G |
1.2
MUs -daily for 10 days -IM |
|
|
500
mg -four times a day for 15 days -oral |
||
|
100
mg -twice daily for 15 days -oral |
||
|
Erythromycin
(2) |
500
mg -four times a day for 15 days -oral |
|
|
Chancroid |
Erythromycin |
500
mg -three times a day for 7 days -oral |
|
Ciprofloxacin
(1) |
500
mg -single dose -oral |
|
|
Ceftriaxone |
250
mg -single dose -IM |
|
|
Spectinomycin |
2
gm -single dose -IM |
|
|
Sulfamethoxazole/
Trimethoprim |
800mg/
160mg -twice daily for 7 days -oral |
|
|
Donovanosis |
Sulfamethoxazole/
Trimethoprim |
800mg/
160mg -twice daily for 14 days -oral |
|
Doxycycline
(1) |
100
mg -twice daily for 7 days |
|
|
Tetracycline
(1) |
500
mg -four times a day for 7 days |
|
|
Chloramphenicol |
500
mg -four times a day for 2 days |
|
|
Trichomononas |
Metronidazole
(3) |
2
g -single dose -oral |
|
Candidosis |
Nystatin
pessaries |
100,000
IU -twice intravaginally for 14 days |
|
Clotrimazole
or miconazole pessaries |
200
mg -once intravaginally for 3 days |
|
|
Miconazole |
500
mg -intravaginally -single dose |
|
|
Bacterial
vaginosis |
Metronidazole
(3) |
400-500
mg -twice a day for 7 days -oral or 2 g -single dose -oral |
|
|
|
<<Back
| CHAPTER FIVE ANNEX FIVE |